MSc Cancer and Molecular Pathology and Genomics
This MSc will give you a theoretical and practical knowledge of modern molecular technologies as applied to human disease, with a focus on cancer. You’ll also learn how to apply and interpret advanced molecular technologies and use them in pathology.
At the heart of the course is a focus on developing your skills in the laboratory, as well as a variety of other scientific and transferable skills. By studying Cancer and Molecular Pathology and Genomics, you’ll equip yourself with the tools to follow a career in academic research, either in the clinical, pharmaceutical or diagnostic setting.
We’ll keep you at the forefront of research: you’ll be taught by internationally renowned lecturers who produce ground-breaking research in cancer biology, genetics, screening, prevention and therapy, so you’ll stay up to date with the most recent medical advances for preventing and treating cancer more effectively.
This programme is delivered by the Barts Cancer Institute, a Cancer Research UK centre of excellence and part of the Cancer Research UK City of London Centre.
This MSc will give you a theoretical and practical knowledge of modern molecular technologies as applied to human disease, with a focus on cancer. You’ll also learn how to apply and interpret advanced molecular technologies and use them in pathology.
At the heart of the course is a focus on developing your skills in the laboratory, as well as a variety of other scientific and transferable skills. By studying Cancer and Molecular Pathology and Genomics, you’ll equip yourself with the tools to follow a career in academic research, either in the clinical, pharmaceutical or diagnostic setting.
We’ll keep you at the forefront of research: you’ll be taught by internationally renowned lecturers who produce ground-breaking research in cancer biology, genetics, screening, prevention and therapy, so you’ll stay up to date with the most recent medical advances for preventing and treating cancer more effectively.
This programme is delivered by the Barts Cancer Institute, a Cancer Research UK centre of excellence and part of the Cancer Research UK City of London Centre.
